Medwave, founded in Danvers, Massachusetts, is dedicated to revolutionizing blood pressure measurement. Their core mission is to create non-invasive, continuous, and highly accurate blood pressure monitoring systems that do not require calibration. The company's flagship product, the Vasotrac system, measures arterial waveforms to calculate blood pressure, meeting all initial goals of accuracy and ease of use. Medwave aims to serve the medical community by providing innovative solutions that enhance patient care.
Notable figures associated with Medwave include its founding team of medical and engineering experts who pioneered the Vasotrac system. The company has garnered attention from investors focused on healthcare innovation. Key achievements include the successful development and implementation of the Vasotrac system in clinical settings, demonstrating significant improvements in patient monitoring. Medwave's impact lies in its contribution to advancing non-invasive medical technologies, potentially setting new standards for blood pressure measurement in healthcare.